Exact Mass: 387.05096140000006

Exact Mass Matches: 387.05096140000006

Found 23 metabolites which its exact mass value is equals to given mass value 387.05096140000006, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Naroparcil

4-{4-[(3,4,5-trihydroxythian-2-yl)sulphanyl]benzoyl}benzonitrile

C19H17NO4S2 (387.0598962)


   
   

2-{2-[3,5-Bis(trifluoromethyl)phenyl]hydrazono}-2-(propylsulfonyl)acetonitrile

2-{2-[3,5-Bis(trifluoromethyl)phenyl]hydrazono}-2-(propylsulfonyl)acetonitrile

C13H11F6N3O2S (387.0476138)


   

Platinum(2+) nitrate ammoniate (1:2:4)

Platinum(2+) nitrate ammoniate (1:2:4)

H12N6O6Pt (387.0466142)


   

Thiazolidine, 2-(4-methylphenyl)-3-[[3-(trifluoromethyl)phenyl]sulfonyl]- (9CI)

Thiazolidine, 2-(4-methylphenyl)-3-[[3-(trifluoromethyl)phenyl]sulfonyl]- (9CI)

C17H16F3NO2S2 (387.0574512)


   

5-bromo-3-[5-(morpholin-4-ylmethyl)-1H-pyridin-2-ylidene]-1H-indol-2-one

5-bromo-3-[5-(morpholin-4-ylmethyl)-1H-pyridin-2-ylidene]-1H-indol-2-one

C18H18BrN3O2 (387.0582308)


   

Benzenesulfonamide,N-(2,4-dinitro-1-naphthalenyl)-4-methyl-

Benzenesulfonamide,N-(2,4-dinitro-1-naphthalenyl)-4-methyl-

C17H13N3O6S (387.05250380000007)


   

Ethylenediaminetetraacetate-copper-ammonia complex

Ethylenediaminetetraacetate-copper-ammonia complex

C10H20CuN4O8 (387.057707)


   
   

4-[4-Bromo-3-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl]phenoxy]benzonitrile

4-[4-Bromo-3-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl]phenoxy]benzonitrile

C19H18BrNO3 (387.0469978)


   

diammonium hexakis(thiocyanato)platinate

diammonium hexakis(thiocyanato)platinate

C6H8N8Pt (387.0519738)


   

4-(3-bromoanilino)-6,7-diethoxyquinazoline

4-(3-bromoanilino)-6,7-diethoxyquinazoline

C18H18BrN3O2 (387.0582308)


   

2,4-dichloro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide

2,4-dichloro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide

C19H15Cl2N3O2 (387.054127)


   

5-(1H-benzimidazol-2-ylmethylidene)-3-(2-naphthalenyl)-2-sulfanylidene-4-thiazolidinone

5-(1H-benzimidazol-2-ylmethylidene)-3-(2-naphthalenyl)-2-sulfanylidene-4-thiazolidinone

C21H13N3OS2 (387.0500008)


   

[(2R,3S,4R,5S)-5-(2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(2R,3S,4R,5S)-5-(2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C12H14N5O8P (387.05799740000003)


   

N-{3-[3-(5-bromo-2-methoxyphenyl)acryloyl]phenyl}propanamide

N-{3-[3-(5-bromo-2-methoxyphenyl)acryloyl]phenyl}propanamide

C19H18BrNO3 (387.0469978)


   

[(3aR,4R,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone

[(3aR,4R,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone

C18H18BrN3O2 (387.0582308)


   

[(3aS,4S,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone

[(3aS,4S,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone

C18H18BrN3O2 (387.0582308)


   

[(3aR,4S,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone

[(3aR,4S,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone

C18H18BrN3O2 (387.0582308)


   

[(3aS,4R,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone

[(3aS,4R,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone

C18H18BrN3O2 (387.0582308)


   

[5-(2-amino-5-carbamoyl-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl dihydrogen phosphate

[5-(2-amino-5-carbamoyl-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl dihydrogen phosphate

C12H14N5O8P (387.05799740000003)


   

CCMI

CCMI

C19H15Cl2N3O2 (387.054127)


CCMI (AVL-3288) is a potent and selective α7 nAChR-positive allosteric modulator, does not bind to or activate α7 nAChRs via the orthosteric site, and causes significant positive modulation of agonist-induced currents at α7 nAChRs. CCMI has potential in CNS diseases with cognitive dysfunction[1].